APA (7th ed.) Citation

Staun-Ram, E., Volkowich, A., Glass-Marmor, L., & Miller, A. (2026). Immunotherapy-Mediated Modulation of the Gut Microbiota in Multiple Sclerosis: The Effects of High-Efficacy (Cladribine) and Moderate-Efficacy (Interferon Beta-1a) Treatments. International Journal of Molecular Sciences, 27(8), 3500. https://doi.org/10.3390/ijms27083500

Chicago Style (17th ed.) Citation

Staun-Ram, Elsebeth, Anat Volkowich, Lea Glass-Marmor, and Ariel Miller. "Immunotherapy-Mediated Modulation of the Gut Microbiota in Multiple Sclerosis: The Effects of High-Efficacy (Cladribine) and Moderate-Efficacy (Interferon Beta-1a) Treatments." International Journal of Molecular Sciences 27, no. 8 (2026): 3500. https://doi.org/10.3390/ijms27083500.

MLA (9th ed.) Citation

Staun-Ram, Elsebeth, et al. "Immunotherapy-Mediated Modulation of the Gut Microbiota in Multiple Sclerosis: The Effects of High-Efficacy (Cladribine) and Moderate-Efficacy (Interferon Beta-1a) Treatments." International Journal of Molecular Sciences, vol. 27, no. 8, 2026, p. 3500, https://doi.org/10.3390/ijms27083500.